跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LANEIGE BB CUSHION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LANEIGE BB CUSHION
Authorized
STANDARD
LANEIGE BB CUSHION
AMOREPACIFIC CORPORATION
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d77791ac73ed6fb8
Company
AMOREPACIFIC CORPORATION
Type
Standard
Approval Details
Approval Id
d77791ac73ed6fb8
Drug Approval Canada Name
LANEIGE BB CUSHION
Product Name
LANEIGE BB CUSHION
Status
Cancelled Post Market
Status Date
2022-03-02
Original Market Date
2018-02-14
Din
02462273
Drug Class
Human
Dosage Form
Lotion
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:80.00
Atc Original
D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION
Atc Name
d 02 ba 30
Aig Number
0327220036
Company Name
AMOREPACIFIC CORPORATION
Company Address
100 Hangang-Daero, Yongsan-Gu, Seoul, Seoul National Capital Area, Korea, Republic Of, 04386
Company Detail Path
/organization/amorepacific-corporation
Company Information
Pharmaceutical Company Name
AMOREPACIFIC CORPORATION
Country Name
South Korea
Province Name
gyeonggi,country_kr
City Name
osan,gyeonggi,country_kr
Address
37 Gajangsaneopdong-ro
Website
http://eng.amorepacific.co.kr/
Active Ingredients
OCTINOXATE
7 % / W/W
TITANIUM DIOXIDE
4.15 % / W/W
ZINC OXIDE
9.8 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d77791ac73ed6fb8
Type
Standard
Back to Health Canada Approvals